SEC Form 4 · accession 0000919484-18-000001
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E Strome
10% Owner
Period of report
May 11, 2018
Accepted (ET)
May 25, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 11, 2018 | P | 8,819,966 | $0.10 | A | 8,819,966 | I | By trust |
| Common StockF1,F2 | May 23, 2018 | P | 4,268,163 | $0.10 | A | 13,088,129 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to Rule 16a-1(a)(4) of the Securities Exchange Act of 1934 ("Exchange Act"), this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
- F2By the Mark E. Strome Living Trust, U/A/D January 15, 1997.